AIMLF News and Press, AI/ML Innovations Inc From 10/15/25

Pilot Study to Lay the Groundwork for Expansion Across Jamaica Goal of the Collaboration is to Demonstrate the Ability to Deliver Affordable, Accurate, and Scalable Holter Diagnostics with CardioYield™ TORONTO, ON, AB / ACCESS Newswire / October 15, 2025 / AI/ML Innovation...

Pilot Evaluation: Toronto Heart Centre to conduct comparative testing of CardioYield™ for enhanced Holter ECG analysis and reporting efficiency. Clinical Workflow Impact: Study to measure time savings, throughput improvements, and analysis quality when using CardioYield™ ver...

Leveraging MaxYield™ ECG to capture real-world exercise data in people living with neurological conditions Generating actionable insights into how cardiac responses may correlate with brain health and outcomes TORONTO, ON / ACCESS Newswire / September 30, 2025 / AI/ML Inno...

2025-09-04 09:05:12 ET More on AI/ML Innovations Inc. Financial information for AI/ML Innovations Inc. Read the full article on Seeking Alpha For further details see: AIML announces $1.55 million private placement

VANCOUVER, BC / ACCESS Newswire / August 8, 2025 / AI/ML Innovations Inc . ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB: 42FB) is pleased to confirm it has closed its previously announced restructuring ("Restructuring") of the terms and conditions associated with its previou...

Neural Cloud Solutions, an AIML subsidiary, files broad provisional patent applications covering advanced neural network architectures and cloud‑based ECG signal optimization workflows Filings enhance the scope of AIML's device‑agnostic ECG enhancement platform, suppor...

Letter of Intent: Circular Health Limited to Enhance ECG Smart Ring with AI-Powered Signal Clarity with multi‑year, per‑user SaaS license targeting commercial launch by September 2025. Global growth catalyst: The collaboration positions both companies to scale AI ...

New board‑level committee will steer regulatory strategy, IP development, and product innovation across AIML's AI‑driven health‑tech portfolio TORONTO, ON / ACCESS Newswire / May 22, 2025 / AI/ML Innovations Inc. (" AIML " or the " Company ") (CSE:AIML)(OTCQB:AIML...

Medical Advisory Board will guide clinical studies, regulatory strategy, and global adoption of AIML's AI‑driven ECG signal‑processing solutions MaxYield™ and CardioYield™ across wearables and cardiology workflows. AIML simultaneously debuts its redesigned corpo...

Proprietary neural network, cloud-based AI-powered technology designed to support clearer ECG signal interpretation across care settings. TORONTO, ON / ACCESS Newswire / May 15, 2025 / AI/ML Innovations Inc . (" AIML " or the " Company ") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a developer of...